Fifth International Prostate Cancer Congress. 1-3 July 2005, Rio Grande, Puerto Rico Journal Article


Author: Slovin, S. F.
Article Title: Fifth International Prostate Cancer Congress. 1-3 July 2005, Rio Grande, Puerto Rico
Abstract: This is an extraordinary time for the treatment of localized and metastatic prostate cancer as manifested by the multi-disciplinary and multi-modality approaches being incorporated into standard technologies. While this is merely a highlight of the current state-of-the-art processes, and does not reflect the importance of any one approach as being superior to the next, the information shared at this meeting will continue to provide a platform, which will establish more diverse treatments. This will not only impact on the disease itself, but may help delay time-to-radiographic progression and improve overall survival. © The Thomson Corporation.
Keywords: unclassified drug; histone deacetylase inhibitor; prednisone; thalidomide; clinical trial; neutropenia; bevacizumab; drug efficacy; drug safety; nonhuman; antineoplastic agents; drug approval; conference paper; paclitaxel; antineoplastic agent; prostate specific antigen; animals; imatinib; carboplatin; bone marrow suppression; kidney disease; neuropathy; neoplasm proteins; calcitriol; antineoplastic activity; drug structure; docetaxel; prostate cancer; prostatic neoplasms; drug mechanism; membrane glycoproteins; granisetron; liver disease; histone deacetylases; retinoic acid; 2 methoxyestradiol; ixabepilone; epothilone b; atrasentan; pyrrolidines; ispinesib; satraplatin; e 7389; leflunomide
Journal Title: IDrugs
Volume: 8
Issue: 9
ISSN: 1369-7056
Publisher: Thomson Reuters (scientific) Ltd  
Date Published: 2005-09-01
Start Page: 710
End Page: 712
Language: English
PUBMED: 16118688
PROVIDER: scopus
DOI/URL:
Notes: --- - "Export Date: 24 October 2012" - "CODEN: IDRUF" - "Source: Scopus"
Citation Impact
MSK Authors
  1. Susan Slovin
    254 Slovin